Adjuvant Chemotherapy for Resected Non-small Cell Lung Cancer

This publication has 36 references indexed in Scilit:

• Meta-Analysis of Postoperative Adjuvant Chemotherapy With Tegafur-Uracil in Non–Small-Cell Lung Cancer
  Journal of Clinical Oncology, 2005
• Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
  New England Journal of Medicine, 2005
• Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer
  Lung Cancer, 2005
• Role of Adjuvant Chemotherapy in Patients With Resected Non–Small-Cell Lung Cancer: Reappraisal With a Meta-Analysis of Randomized Controlled Trials
  Journal of Clinical Oncology, 2004
• Chemotherapy for patients with non-small cell lung cancer: the surgical setting of the Big Lung Trial1
  European Journal of Cardio-Thoracic Surgery, 2004
• O-58 Quality of life in a trial of adjuvant chemotherapy for early stage completely resected non-small cell lung cancer (NCIC CTG BR.10)
  Lung Cancer, 2003
• Global cancer statistics in the year 2000
  The Lancet Oncology, 2001
• Postoperative oral administration of UFT for completely resected pathologic stage I non-small cell lung cancer: the West Japan study group for lung cancer surgery (WJSG), the 4th study
  European Journal Of Cancer, 2001
• Adjuvant radiotherapy versus combined sequential chemotherapy followed by radiotherapy in the treatment of resected nonsmall cell lung carcinoma. A randomized trial of 267 patients
  Cancer, 1995
• A randomized trial of postoperative adjuvant chemotherapy in non-small cell lung cancer (the second cooperative study)
  European Journal of Surgical Oncology, 1995